Semaglutide for Weight Loss: How It Works

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has emerged as one of the most effective weight loss medications available, with clinical trials showing an average weight reduction of 15% over 68 weeks. This injectable GLP-1 therapy works by mimicking a natural hormone that regulates appetite and glucose metabolism. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies to patients across all 50 states, starting at $149 per month.

What Is Semaglutide and How Does It Work for Weight Loss?

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist—a medication that activates receptors in your brain responsible for appetite regulation and blood sugar control. When you inject semaglutide, it signals your body that you are full, reducing food cravings and portion sizes naturally. The drug also slows gastric emptying, meaning food stays in your stomach longer, extending the sensation of fullness between meals.

Beyond appetite suppression, semaglutide improves how your body processes glucose, which helps stabilize energy levels and reduce sugar crashes that trigger overeating. Studies show that patients on semaglutide lose weight even when they are not actively restricting calories, because the medication addresses the biological drivers of weight gain. This mechanism makes it particularly effective for people whose excess weight is linked to hunger dysregulation or metabolic imbalance.

Clinical Evidence: Weight Loss Results and Timeline

The landmark STEP trial, which followed over 4,500 patients, demonstrated that semaglutide produced an average weight loss of 15% of body weight over one year—roughly double the loss seen with diet and exercise alone. Patients starting at lower doses typically see initial weight loss within 4–6 weeks, with more substantial results appearing by 12–16 weeks as doses are optimized. Individual results vary based on adherence, baseline metabolism, genetic predisposition, and whether the medication is paired with consistent nutrition and movement habits.

Long-term data shows that weight loss plateaus around 6–12 months and remains stable as long as patients continue the medication. Weight regain occurs in most people who stop using semaglutide without establishing sustainable lifestyle habits, which is why ongoing therapy is often recommended. PlexusDx patients may benefit from the Precision Peptide Genetic Test, which identifies individual variations in GLP-1 receptor sensitivity (GLP1R rs6923761) and other metabolic pathways, helping predict response intensity.

Side Effects and Safety Considerations

The most common side effects of semaglutide are gastrointestinal—nausea, vomiting, constipation, and diarrhea—which typically peak during dose escalation and resolve within 2–4 weeks as your body adjusts. These effects are dose-dependent and often mild at the lower starting doses that PlexusDx prescribes initially. Staying hydrated, eating smaller meals, and taking time between dose increases significantly reduces nausea in most patients.

Rare but serious risks include pancreatitis (inflammation of the pancreas), gallbladder issues, and changes in vision, which warrant immediate medical attention if they occur. Semaglutide is not recommended for patients with a personal or family history of medullary thyroid cancer or those with type 2 multiple endocrine neoplasia syndrome. PlexusDx requires a telehealth consultation with a licensed provider to rule out contraindications before treatment begins, ensuring medication safety for your unique health profile.

PlexusDx Compounded Semaglutide vs. Brand-Name Ozempic

PlexusDx sources semaglutide from licensed 503A compounding pharmacies, which manufacture the medication to pharmaceutical standards under strict quality control. Compounded semaglutide is chemically identical to brand-name Ozempic but costs significantly less—starting at $149 per month—because it bypasses brand markups and does not require insurance coverage. Patients can use HSA or FSA funds to pay for PlexusDx treatment, increasing affordability for eligible individuals.

Unlike Ozempic's fixed-dose pens, compounded semaglutide allows for more precise dose customization, which can be helpful for patients who are particularly sensitive to side effects or need fine-tuned escalation. All PlexusDx medications come with a licensed provider consultation and ongoing telehealth support—there is no membership fee, and PlexusDx serves all 50 states. Your dose may need to go up as your body adapts; your price will not, because PlexusDx charges a flat monthly rate regardless of dose strength.

How to Get Started with Semaglutide Through PlexusDx

Starting semaglutide with PlexusDx begins with a brief telehealth intake where a licensed provider reviews your medical history, weight loss goals, and any contraindications. Once approved, your first dose (typically 0.25 mg) is shipped directly to your home with clear injection instructions and storage guidelines. PlexusDx also provides ongoing provider support via secure messaging if you experience side effects or have questions during your treatment.

Most patients increase their dose every 4 weeks by 0.25 mg increments until reaching their optimal maintenance dose, usually between 1.0 and 2.4 mg weekly. PlexusDx offers optional genetic testing through the Precision Peptide Genetic Test—a 49-peptide pathway analysis that reveals whether you carry variants in GLP-1 receptor genes or other metabolic pathways that influence medication response. This personalized insight helps your provider adjust your protocol for maximum results.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I lose weight on semaglutide?

Most patients notice reduced hunger within days, but measurable weight loss typically appears in 4–6 weeks. The average loss accelerates to 1–2 pounds per week after 8–12 weeks as your dose reaches therapeutic levels. Your individual timeline depends on your starting weight, adherence, diet quality, and genetic factors—PlexusDx's Precision Pepti...

Is compounded semaglutide as effective as Ozempic?

Yes. Compounded semaglutide from licensed 503A pharmacies contains the identical active ingredient and produces the same weight loss and metabolic benefits as brand-name Ozempic. The only meaningful difference is cost—PlexusDx compounded semaglutide starts at $149/month, significantly less than Ozempic's typical insurance copay or out-of-pocket ...

Can I use my insurance with PlexusDx semaglutide?

PlexusDx does not bill insurance, which is why pricing is predictable and low. However, you can use HSA or FSA funds to pay for treatment at no out-of-pocket cost if you have eligible accounts. This approach often saves money compared to insurance copays for weight loss medications.

What happens if I stop taking semaglutide?

Weight typically returns within 6–12 months after stopping, because semaglutide addresses appetite regulation but does not permanently reset hunger hormones. Most patients stay on long-term therapy to maintain results, though some successfully transition to lower maintenance doses. Combining semaglutide with sustainable nutrition and exercise ha...

How does the Precision Peptide Genetic Test help personalize my semaglutide therapy?

PlexusDx's genetic test analyzes 14 metabolic pathways and 49 peptides, including key GLP-1 receptor variants (GLP1R rs6923761) and appetite-regulation genes (FTO rs9939609, MC4R rs17782313). Results reveal whether you are a rapid responder, standard responder, or someone who may benefit from a dual-compound therapy like GLP-Squared, optimizing ...

Ozempic for Weight Loss A Comprehensive Guide